Last June, we hosted our most successful webinar of 2023, in which we discussed how enhanced integration between Quality Control and the rest of the supply chain can dramatically optimize end-to-end product release lead times. That session generated a lot of interest but it doesn’t have to stop here!
Now it’s time to go one step further:
Based on clients insights, Bluecrux has developed a comprehensive standardized model to help pharma companies of all sizes assess and improve their QC-SC optimization. The model has been designed to guide organizations both in identifying their current status and in setting attainable goals to advance their operational maturity at the team, departmental and site levels.
The model includes: